Epitomee Medical Ltd (TLV: EPIT)

Epitomee Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	13.12	15.63	35.95
Short-Term Investments	11.81	19.16	10.18
Cash & Short-Term Investments	24.93	34.79	46.13
Cash Growth	-28.33%	-24.59%	-
Other Receivables	0.3	0.17	0.18
Receivables	0.3	0.17	0.18
Prepaid Expenses	-	0.03	0.06
Other Current Assets	0.23	0.07	0.13
Total Current Assets	25.47	35.06	46.51
Property, Plant & Equipment	16.06	4.93	8.42
Other Long-Term Assets	0.28	0.27	0.28
Total Assets	41.81	40.27	55.2
Accounts Payable	0.62	0.54	0.31
Accrued Expenses	-	0.96	1.37
Current Portion of Leases	0.58	0.45	0.49
Other Current Liabilities	0.71	0	0
Total Current Liabilities	1.9	1.96	2.16
Long-Term Leases	3.78	3.51	3.6
Long-Term Unearned Revenue	-	-	10
Total Liabilities	5.68	5.47	15.76
Common Stock	90.2	0.81	0.81
Additional Paid-In Capital	4.28	93.17	92.14
Retained Earnings	-58.73	-59.56	-53.87
Comprehensive Income & Other	0.38	0.38	0.38
Shareholders' Equity	36.13	34.8	39.45
Total Liabilities & Equity	41.81	40.27	55.2
Total Debt	4.36	3.96	4.08
Net Cash (Debt)	20.58	30.83	42.05
Net Cash Growth	-33.25%	-26.67%	-
Net Cash Per Share	0.66	1.04	1.43
Filing Date Shares Outstanding	29.76	29.52	29.46
Total Common Shares Outstanding	29.76	29.52	29.46
Working Capital	23.57	33.1	44.34
Book Value Per Share	1.21	1.18	1.34
Tangible Book Value	36.13	34.8	39.45
Tangible Book Value Per Share	1.21	1.18	1.34
Machinery	-	1.07	3.89
Leasehold Improvements	-	0.17	1.18

Source: S&P Capital IQ. Standard template. Financial Sources.